LONDON (ShareCast) - Venn Life Sciences has won two contracts to provide a number of clinical trial-management services across Europe.

The first contract is with a global pharmaceutical company to conduct a Phase IV drug interaction study and the second is with a leading US biotech company to manage a multi-national study. The group said it could not name either of the companies due to confidentiality agreements.

The new deals, combined with other recent contract wins, will contribute €0.9m in additional revenue for the financial year to December 31st 2013.

Venn also announced it has opened a new office in the UK and has appointed Stewart Hulse as Vice President of Resourcing.

"These recent business wins and the expansion of our business are in line with our goals as set out earlier this year," Chief Executive Officer, Tony Richardson, said.

"We have targeted medical devices as a key growth area and the recent project win is a welcome endorsement of our capabilities. Securing preferred vendor status with top ten Pharma is a major achievement for a company of our current scale and reflects well on the robustness of our business."

RD

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE